Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Other financing activities (2020 - 2025)

Historic Other financing activities for Alignment Healthcare (ALHC) over the last 6 years, with Q1 2025 value amounting to $26000.0.

  • Alignment Healthcare's Other financing activities rose 7333.33% to $26000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year increase of 139120.29%. This contributed to the annual value of $8.8 million for FY2024, which is 827333.33% up from last year.
  • As of Q1 2025, Alignment Healthcare's Other financing activities stood at $26000.0, which was up 7333.33% from $8.3 million recorded in Q4 2024.
  • In the past 5 years, Alignment Healthcare's Other financing activities registered a high of $25.5 million during Q1 2021, and its lowest value of $15000.0 during Q1 2024.
  • Its 5-year average for Other financing activities is $3.9 million, with a median of $497000.0 in 2024.
  • Its Other financing activities has fluctuated over the past 5 years, first tumbled by 9243.7% in 2023, then skyrocketed by 1830000.0% in 2024.
  • Alignment Healthcare's Other financing activities (Quarter) stood at $3.5 million in 2021, then tumbled by 83.21% to $595000.0 in 2022, then plummeted by 92.44% to $45000.0 in 2023, then soared by 18300.0% to $8.3 million in 2024, then plummeted by 99.69% to $26000.0 in 2025.
  • Its last three reported values are $26000.0 in Q1 2025, $8.3 million for Q4 2024, and $497000.0 during Q2 2024.